Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.
Also called NCT01413841
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT01413841
-
- Other papers using this trial's data
- The analgesic effect of oxygen during percutaneous coronary intervention (the OXYPAIN Trial)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Sweden
- Registry status
- Completed
Technical summary
Registry record NCT01413841. Randomized; triple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
- Acronym
- OXYPAIN
- Condition
- Angina
- Intervention (Drug)
- Nasal oxygen
- Intervention (Drug)
- Regular nasal air
- Lead sponsor
- Region Skane
Record details
- Record id
cardio:ct-nct01413841- Content hash
a7305f3a4355f6aff11a076f199d456f402bbbbdbe5bebad8e47caad5bc317e3